Abstract

Introduction: Cell therapy for myocardial angiogenesis or regeneration is currently subject of clinical pilot trials. Suitable inclusion criteria, however, remain to be defined.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call